GGrantIndex
← Leaderboards

Pai Life Sciences, Inc.

Seattle, WA

Compare ↔
$24,183,456
Total funding
27
Grants

Funding over time

peak $4.4M · FY200725
$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$23,940,456 · 26
CDC$243,000 · 1

By mechanism

R44$13,639,874 · 5
N44$4,448,622 · 2
R43$3,271,360 · 12
N43$1,993,977 · 5
R41$452,787 · 2
R21$376,836 · 1

Investigators at Pai Life Sciences, Inc.

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Emerging Leaders

6–10 yrs in

Not enough data

Largest grants

Phase II - Development of a Prophylactic Onchocerciasis Vaccine$2,961,685
N44 · FY2019 · AI
INHALED DRUG COMBINATION FOR TUBERCULOSIS THERAPY$1,486,937
N44 · FY2015 · AI
A Vaccine for Schistosomiasis, "SchistoShield"$1,380,664
R44 · FY2017 · AI
A Vaccine for Schistosomiasis, "SchistoShield"$1,288,089
R44 · FY2018 · AI
A Vaccine for Schistosomiasis, "SchistoShield"$1,159,786
R44 · FY2016 · AI
A Vaccine for Lymphatic Filariasis, LFGuard™$1,000,000
R44 · FY2021 · AI
A Vaccine for Lymphatic Filariasis, LFGuard™$1,000,000
R44 · FY2022 · AI
A Vaccine for Lymphatic Filariasis, LFGuard™$1,000,000
R44 · FY2020 · AI
A Vaccine for Lymphatic Filariasis, LFGuard™$995,460
R44 · FY2024 · AI
Reducing Complement Inhibition to Treat Leukemia and Lymphoma$833,191
R44 · FY2013 · CA
Reducing Complement Inhibition to Treat Leukemia and Lymphoma$812,715
R44 · FY2014 · CA
JOC-x: Chemotherapy conjugates that open tumor tight junctions to treat cancer$720,945
R44 · FY2019 · CA
A Vaccine for Schistosomiasis, "SchistoShield"$706,627
R44 · FY2020 · AI
LATE STAGE ADJUVANT MIMICS BASED ON TLR4 AGONISTS$597,953
N43 · FY2022 · AI
JOC-x: Chemotherapy conjugates that open tumor tight junctions to treat cancer$556,615
R44 · FY2020 · CA
A Vaccine for Schistosomiasis, "SchistoShield"$506,495
R44 · FY2022 · AI
A Vaccine for Schistosomiasis, "SchistoShield"$506,495
R44 · FY2021 · AI
A Vaccine for Lymphatic Filariasis, LFGuard™$452,996
R44 · FY2025 · AI
COMBINING PARASITE AND VECTOR COMPONENTS FOR DEVELOPMENT OF A LEISHMANIA VACCINE$444,428
N43 · FY2016 · AI
DEVELOPMENT OF A PROPHYLACTIC ONCHOCERCIASIS VACCINE$441,905
N43 · FY2016 · AI